TransMedics Group Inc
Company Profile
Business description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact
200 Minuteman Road
AndoverMA01810
USAT: +1 978 552-0900
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
728
Stocks News & Analysis
stocks
Tesla: Board announces new pay package for CEO Elon Musk
stocks
Has the most hated company on the ASX 200 bounced back?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,922.00 | 4.90 | 0.05% |
CAC 40 | 7,632.01 | 85.85 | 1.14% |
DAX 40 | 23,757.69 | 331.72 | 1.42% |
Dow JONES (US) | 44,173.64 | 585.06 | 1.34% |
FTSE 100 | 9,128.30 | 59.72 | 0.66% |
HKSE | 24,733.45 | 225.64 | 0.92% |
NASDAQ | 21,053.58 | 403.45 | 1.95% |
Nikkei 225 | 40,290.70 | 508.90 | -1.25% |
NZX 50 Index | 12,780.58 | 96.54 | 0.76% |
S&P 500 | 6,329.94 | 91.93 | 1.47% |
S&P/ASX 200 | 8,663.70 | 1.70 | 0.02% |
SSE Composite Index | 3,583.31 | 23.36 | 0.66% |